Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Collaboration
Vertex to pay $25M upfront to scale cell manufacturing technology
By
LabPulse.com staff writers
As part of the deal, Vertex was also willing to pay up to $215 million in milestones achieved in connection with the development of a scaled-up process for fully differentiated islet cells.
April 25, 2024
Nightingale Health to open U.S. lab, collaborate with Englander Institute at Weill Cornell
By
LabPulse.com staff writers
Preventive healthcare company Nightingale Health will open a laboratory in the U.S. In addition, the Englander Institute for Precision Medicine at Weill Cornell Medicine has signed on as its first customer.
April 17, 2024
Oxford Nanopore, SeqOne to collaborate on sequencing platform
By
LabPulse.com staff writers
Oxford Nanopore and genomics firm SeqOne are collaborating on an end-to-end platform for whole-genome nanopore sequencing reads for clinical diagnostic testing.
March 18, 2024
NGeneBio, Genolution to collaborate on automated NGS system
By
LabPulse.com staff writers
Precision diagnostics company NGeneBio and molecular diagnostics firm Genolution have signed a memorandum of understanding to develop and launch an automated next-generation sequencing (NGS) system.
March 14, 2024
Ginkgo Bioworks launches technology network
By
Matt Limb
Ginkgo Bioworks has launched a new technology network with 25 partners, pledging to improve customers’ research and development outcomes.
March 6, 2024
Ibex, PathPresenter ink partnership
By
LabPulse.com staff writers
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to enable wider use of AI-enabled digital pathology for their joint customers.
March 6, 2024
International consortium aims to develop precision approach for CVD
By
Matt Limb
An international collaboration has begun to develop personalized treatments for patients with cardiovascular disease, combining genetic analysis and better integration of health data.
February 21, 2024
Intellia Therapeutics, ReCode Therapeutics to collaborate on genomic medicines for CF
By
LabPulse.com staff writers
Gene-editing firm Intellia Therapeutics and biotech company ReCode Therapeutics have entered into a strategic collaboration aimed at developing genomic medicines for the treatment of cystic fibrosis (CF).
February 16, 2024
Oxford Nanopore, Lonza to collaborate on QC test for mRNA therapeutics
By
LabPulse.com staff writers
Oxford Nanopore will collaborate with biotech manufacturer Lonza on commercializing a cGMP-validated test to enable advanced analysis for quality attributes of mRNA products.
January 31, 2024
BD, Techcyte team for AI-enabled digital cervical cytology system
By
LabPulse.com staff writers
Becton Dickinson (BD) and Techcyte have announced a strategic collaboration agreement designed to, in time, add artificial intelligence (AI) to cervical cancer screening in the U.S.
January 30, 2024
Concentric by Ginkgo, Illumina to collaborate on biosurveillance technology
By
Matt Limb
Illumina and biosecurity firm Concentric by Ginkgo have pledged to expand biosecurity capabilities to help countries “modernize defenses" against emerging biological threats.
January 24, 2024
Optithera, ELNA Medical Group, Génome Québec partner on diabetes complications risk assessment test
By
LabPulse.com staff writers
Optithera, ELNA Medical Group, and Génome Québec have signed an agreement to further develop and distribute a genomic test to predict the risk of complications in patients with type 2 diabetes.
January 18, 2024
Page 1 of 40
Next Page